Clincosm LogoSign in Get a demo

stage iii melanoma

Showing 1 - 25 of 26
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Improve Early Detection of Cancer Recurrence in High-Risk

Recruiting
  • Stage III Melanoma
  • Stage IV Cutaneous Melanoma
    • Cleveland, Ohio
      Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Ca
    Oct 6, 2022

    Unresectable Melanoma, Metastatic Melanoma, Stage III Melanoma Trial in Boston (Sargramostim (GM-CSF), Pembrolizumab

    Recruiting
    • Unresectable Melanoma
    • +3 more
    • Sargramostim (GM-CSF)
    • Pembrolizumab (anti-PD-1)
    • Boston, Massachusetts
    • +1 more
    Jul 6, 2022

    Stage III Melanoma, Stage IV Melanoma Trial in Los Angeles, Denver (TBX-3400)

    Recruiting
    • Stage III Melanoma
    • Stage IV Melanoma
    • TBX-3400
    • Los Angeles, California
    • +1 more
    May 1, 2022

    Stage IV Melanoma, Stage III Melanoma Trial in Jette (Trametinib, Dabrafenib)

    Recruiting
    • Stage IV Melanoma
    • Stage III Melanoma
    • Jette, Brussels, Belgium
      Universitair Ziekenhuis Brussel
    Sep 29, 2021

    Stage III Melanoma, Stage IV Melanoma, Unresectable Melanoma Trial in Chapel Hill (BRAF inhibitor dabrafenib and MEK inhibitor

    Completed
    Has Results
    • Stage III Melanoma
    • +3 more
    • BRAF inhibitor dabrafenib and MEK inhibitor trametinib
    • Chapel Hill, North Carolina
      Lineberger Comprehensive Cancer Center, University of North Caro
    Nov 3, 2020

    Metastatic Melanoma, Stage III Melanoma, Stage IV Melanoma Trial in United States (Indoximod, Ipilimumab, Nivolumab)

    Completed
    • Metastatic Melanoma
    • +2 more
    • Augusta, Georgia
    • +5 more
    Jun 3, 2020

    Stage IV Melanoma, Stage III Melanoma Trial in Australia (IMP321 (eftilagimod alpha), Pembrolizumab)

    Completed
    • Stage IV Melanoma
    • Stage III Melanoma
    • Brisbane, Queensland, Australia
    • +6 more
    Dec 17, 2019

    Stage III Melanoma, Stage IV Melanoma, Unresectable Melanoma Trial in Orange (Pazopanib and Paclitaxel)

    Completed
    Has Results
    • Stage III Melanoma
    • +2 more
    • Pazopanib and Paclitaxel
    • Orange, California
      Chao Family Comprehensive Cancer Center
    Aug 5, 2019

    Unresectable Malignant Tumor, Melanoma, Metastatic Melanoma Trial in Saint Louis (Pembrolizumab)

    Completed
    Has Results
    • Unresectable Malignant Neoplasm
    • +4 more
    • Saint Louis, Missouri
      Saint Louis University Hospital
    Jun 3, 2019

    Stage IV Melanoma, Stage III Melanoma Trial in United States (Autologous Dendritic Cell-Tumor Cell Immunotherapy (DC-TC),

    Terminated
    • Stage IV Melanoma
    • Stage III Melanoma
    • Autologous Dendritic Cell-Tumor Cell Immunotherapy (DC-TC)
    • Autologous PBMCs in GM-CSF (MC)
    • Irvine, California
    • +17 more
    May 9, 2019

    Recurrent Melanoma, Stage III Melanoma, Stage IV Melanoma Trial in Philadelphia (drug, biological, other)

    Completed
    Has Results
    • Recurrent Melanoma
    • +3 more
    • imatinib mesylate
    • +3 more
    • Philadelphia, Pennsylvania
      Abramson Cancer Center of The University of Pennsylvania
    May 23, 2018

    Interferon Toxicities in Melanoma Treatment

    Completed
    • Stage III Melanoma
      • (no location specified)
      Jun 6, 2016

      Stage III Melanoma, Stage IV Melanoma Trial in Vienna (Ofatumumab, Ofatumumab plus Dacarbazine)

      Completed
      • Stage III Melanoma
      • Stage IV Melanoma
      • Ofatumumab
      • Ofatumumab plus Dacarbazine
      • Vienna, Austria
      • +1 more
      Oct 4, 2015

      Melanoma, Recurrent Melanoma, Stage III Melanoma Trial in Houston (sorafenib tosylate, temsirolimus)

      Completed
      • Melanoma
      • +3 more
      • Houston, Texas
        M D Anderson Cancer Center
      Apr 9, 2014

      Recurrent Melanoma, Stage III Melanoma Trial in Durham (drug, biological, other)

      Completed
      • Recurrent Melanoma
      • Stage III Melanoma
      • isolated limb perfusion
      • +4 more
      • Durham, North Carolina
        American College of Surgeons Oncology Group
      Jul 15, 2013

      Stage IV Melanoma, Stage III Melanoma, Recurrent Melanoma Trial (dendritic cell-gp100-MART-1 antigen vaccine, sargramostim)

      Completed
      • Stage IV Melanoma
      • +2 more
      • (no location specified)
      Jun 19, 2013

      Stage III Melanoma, Stage IV Melanoma Trial in Houston (cilengitide, pharmacological study, laboratory biomarker analysis)

      Terminated
      • Stage III Melanoma
      • Stage IV Melanoma
      • Houston, Texas
        M D Anderson Cancer Center
      Jun 4, 2013

      Recurrent Melanoma, Recurrent Renal Cell Cancer, Stage III Melanoma Trial in New Haven (recombinant interferon alfa-2b,

      Completed
      • Recurrent Melanoma
      • +4 more
      • New Haven, Connecticut
        Yale University
      May 1, 2013

      Recurrent Melanoma, Stage III Melanoma, Stage IV Melanoma Trial in New York (tanespimycin, laboratory biomarker analysis)

      Terminated
      • Recurrent Melanoma
      • +2 more
      • New York, New York
        Memorial Sloan-Kettering Cancer Center
      Apr 9, 2013

      Male Breast Cancer, Recurrent Bladder Cancer, Recurrent Breast Cancer Trial in Los Angeles (decitabine, pharmacological study,

      Completed
      • Male Breast Cancer
      • +8 more
      • Los Angeles, California
        University of Southern California
      Feb 6, 2013

      Stage III Melanoma, Stage IV Melanoma Trial in Bronx (sorafenib tosylate, laboratory biomarker analysis)

      Completed
      • Stage III Melanoma
      • Stage IV Melanoma
      • sorafenib tosylate
      • laboratory biomarker analysis
      • Bronx, New York
        Montefiore Medical Center
      Jan 14, 2013

      Stage III Melanoma, Stage IV Melanoma Trial in Los Angeles, Stuart, Las Vegas (MKC1106-MT)

      Terminated
      • Stage III Melanoma
      • Stage IV Melanoma
      • MKC1106-MT
      • Los Angeles, California
      • +3 more
      May 10, 2012

      Recurrent Melanoma, Stage III Melanoma, Stage IV Melanoma Trial in Seattle (biological, procedure, other, genetic)

      Terminated
      • Recurrent Melanoma
      • +2 more
      • therapeutic autologous lymphocytes
      • +6 more
      • Seattle, Washington
        Fred Hutchinson Cancer Research Center/University of Washington
      Dec 2, 2011

      Stage IV Melanoma, Stage III Melanoma, Recurrent Melanoma Trial in Rochester, Buffalo, Dallas (allovectin-7)

      Completed
      • Stage IV Melanoma
      • +2 more
      • Rochester, Minnesota
      • +2 more
      Jul 5, 2011

      Malignant Skin Melanoma T0, Stage III Melanoma, Stage IV Melanoma Trial in Paris (Nilotinib)

      Unknown status
      • Malignant Skin Melanoma T0
      • +3 more
      • Paris, France
        Hôpital Saint-Louis
      Feb 7, 2011